Cross-fund · 5 holders
NVCR
NOVOCURE LTD
CUSIP G6674U108
5
Tracked holders
$303.5M
Aggregate value
25,802,816
Shares
5
Active funds
Funds holding NVCR
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $143.8M | — | −347,683 | −2.6% |
| Vanguard | Institutional | Q4 2025 | $141.7M | — | +502,368 | +4.8% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $14.8M | 0.02% | +460,895 | +51.2% |
| Citadel | Multi-Strategy | Q1 2026 | $2.2M | — | −710,895 | −78.2% |
| Millennium | Multi-Strategy | Q1 2026 | $994,244 | — | −555,451 | −85.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.